4.8 Review

Ru(II) dyads derived from α-oligothiophenes: A new class of potent and versatile photosensitizers for PDT

Journal

COORDINATION CHEMISTRY REVIEWS
Volume 282, Issue -, Pages 127-138

Publisher

ELSEVIER SCIENCE SA
DOI: 10.1016/j.ccr.2014.04.012

Keywords

Photodynamic therapy; Photosensitizers; Metal complexes; alpha-Oligothiophenes; DNA damage; Nuclear targeting

Funding

  1. Canadian Institutes of Health Research
  2. Natural Sciences and Engineering Research Council of Canada
  3. Canadian Foundation for Innovation
  4. Nova Scotia Research and Innovation Trust
  5. Beatrice Hunter Cancer Research Institute

Ask authors/readers for more resources

Ru(II) dyads derived from organic units that impart low-lying (IL)-I-3 excited states combine the most attractive features of organic photosensitizers with those of coordination complexes. The result is a bichromophoric system with excited-state lifetimes that are significantly longer than those associated with traditional (MLCT)-M-3 states. Incorporation of alpha-oligothiophenes as the organic chromophore leads to systems that act as dual Type I/II photosensitizers, opening up the possibility of treating hypoxic tumors with photodynamic therapy (PDT) and overcoming problems with in vivo dosimetry. These photosensitizers, particularly those that consist of three thiophene units and higher, are remarkable DNA binders and photocleavers when exposed to light, exhibiting no interference with DNA structural integrity in the absence of a light-trigger. Such light-responsive agents localize in the nuclei of cells without the need for a carrier and produce a potent PDT response with minimal dark toxicity. This phototherapeutic effect translates directly to animals and is superior to the clinical agent Photofrin (R) in this model. These Ru(II) dyads can be activated with light in the PDT window, despite very low molar extinction coefficients in this region, and this phenomenon can be attributed to the efficiency with which these agents operate. The ability to activate these prodrugs with ultraviolet to near-infrared light marks an unprecedented versatility that can be exploited to match treatment depth to tumor invasion depth without compromising potency, giving rise to photosensitizers for multiwavelength PDT. (C) 2014 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available